Do immune inflammatory markers correlate with anal dysplasia and anal cancer risk in patients living with HIV?

Jonathan StemQiuyu YangEvie H Carchman Robert Striker Cristina B Geltzeiler

Published in: International journal of colorectal disease (2022)

NLR values in patients living with HIV correlate with risk of anal cancer and increasing grades of dysplasia. A cutoff NLR of ≥ 1.64 can be used to help capture those at risk. NLR is a promising marker of risk of anal cancer and progression of anal dysplasia in patients with HIV infection and could be used to risk-stratify screening and surveillance intervals.

Keyphrases

end stage renal disease
high grade
ejection fraction
newly diagnosed
peritoneal dialysis
papillary thyroid
public health
squamous cell carcinoma
patient reported